Halozyme Therapeutics Inc(HALO)
56.20
Change: -1.68 (▼ -2.99%)
As of Tue 12/20/2022 08:35 AM% Of Value
Growth
Value Per Share
:
:
:
618.82
65.67
10.8800 (as of 19/12/2022)
Fundamentals Data
| Open | 56.88 | Dividend | 123 |
| Close Price | 56.20 | DivYield | 0 % |
| High | 57.12 | Growth | 175.7 M |
| Low | 55.74 | Growth% | 65.67 |
| P/e | -29.989 | Volume | 735,158.0 |
| P/b | -0.52 | Market Capital | 7.6 B |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 50.92 (as of 20/12/2022) | 50 Days Moving Average Percentage | 10.709801858671 (as of 20/12/2022 |
| Industry: Biotechnology: Biological Products (No Diagnostic Substances) |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2017 | Year2 / 2018 | Year3 / 2019 | Year4 / 2020 | Current Year / 2021 |
| Revenue | 316.6 M | 151.8 M | 195.9 M | 267.5 M | 443.3 M |
| Cap Spending | -1.3 M | -4.6 M | -4.0 M | -1.4 M | -1.4 M |
| Operating Expenses | 204.4 M | 211.0 M | 218.0 M | 79.9 M | 85.9 M |
| Operating Cash Flow | 81.0 M | -69.3 M | -67.6 M | 144.2 M | 275.9 M |
| Free Cash Flow | 132.7 M | -54.1 M | -89.4 M | 54.0 M | 297.9 M |
| Free Cash Flow Per Share | 0.973 | -0.377 | -0.62 | 0.397 | 2.119 |
| Total liabilities | 202.3 M | 126.3 M | 402.5 M | 397.2 M | 876.6 M |
| Total cash | 169.2 M | 58.4 M | 120.6 M | 148.2 M | 119.2 M |
| ROE% | 0.898 | -0.319 | -0.337 | 1.248 | 2.419 |
| Outstanding Shares | 143.0 M | 145.0 M | 138.2 M | 135.2 M | 137.7 M |
| P/E | 41.988 | -29.989 | -41.005 | 49.474 | 11.212 |
| P/S | 8.351 | 15.863 | 15.114 | 23.866 | 10.185 |
| Revenue USD | 316.6 M | 151.8 M | 195.9 M | 267.5 M | 443.3 M |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|